Literature DB >> 25798614

Transcriptional regulation of autophagy in RAS-driven cancers.

Ravi K Amaravadi.   

Abstract

RAS-driven cancers exhibit variable dependency on autophagy for survival; however, it is not fully understood how. In this issue of the JCI, Cheong and colleagues demonstrate that RAS-dependent elevation of casein kinase 1α (CK1α) negatively regulates autophagy at the level of autophagy gene transcription. Moreover, combined inhibition of both CK1α and autophagy reduced proliferation of RAS-driven tumors. The results of this study provide insight into the connection between mutant RAS and autophagy, and suggest targeting CK1α as a potential therapeutic strategy to modulate autophagy in RAS-driven cancers.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25798614      PMCID: PMC4409024          DOI: 10.1172/JCI81504

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

Review 1.  Regulation of autophagy by stress-responsive transcription factors.

Authors:  Federico Pietrocola; Valentina Izzo; Mireia Niso-Santano; Erika Vacchelli; Lorenzo Galluzzi; Maria Chiara Maiuri; Guido Kroemer
Journal:  Semin Cancer Biol       Date:  2013-05-30       Impact factor: 15.707

2.  Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma.

Authors:  Dan T Vogl; Edward A Stadtmauer; Kay-See Tan; Daniel F Heitjan; Lisa E Davis; Laura Pontiggia; Reshma Rangwala; Shengfu Piao; Yunyoung C Chang; Emma C Scott; Thomas M Paul; Charles W Nichols; David L Porter; Janeen Kaplan; Gayle Mallon; James E Bradner; Ravi K Amaravadi
Journal:  Autophagy       Date:  2014-05-20       Impact factor: 16.016

3.  The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis.

Authors:  Agnes Roczniak-Ferguson; Constance S Petit; Florian Froehlich; Sharon Qian; Jennifer Ky; Brittany Angarola; Tobias C Walther; Shawn M Ferguson
Journal:  Sci Signal       Date:  2012-06-12       Impact factor: 8.192

4.  Combined autophagy and HDAC inhibition: a phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumors.

Authors:  Devalingam Mahalingam; Monica Mita; John Sarantopoulos; Leslie Wood; Ravi K Amaravadi; Lisa E Davis; Alain C Mita; Tyler J Curiel; Claudia M Espitia; Steffan T Nawrocki; Francis J Giles; Jennifer S Carew
Journal:  Autophagy       Date:  2014-05-20       Impact factor: 16.016

5.  Phase I clinical trial and pharmacodynamic evaluation of combination hydroxychloroquine and doxorubicin treatment in pet dogs treated for spontaneously occurring lymphoma.

Authors:  Rebecca A Barnard; Luke A Wittenburg; Ravi K Amaravadi; Daniel L Gustafson; Andrew Thorburn; Douglas H Thamm
Journal:  Autophagy       Date:  2014-05-20       Impact factor: 16.016

Review 6.  Autophagy modulation as a potential therapeutic target for diverse diseases.

Authors:  David C Rubinsztein; Patrice Codogno; Beth Levine
Journal:  Nat Rev Drug Discov       Date:  2012-09       Impact factor: 84.694

7.  K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions.

Authors:  Jonathan M Ostrem; Ulf Peters; Martin L Sos; James A Wells; Kevan M Shokat
Journal:  Nature       Date:  2013-11-20       Impact factor: 49.962

8.  Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma.

Authors:  Reshma Rangwala; Robert Leone; Yunyoung C Chang; Leslie A Fecher; Lynn M Schuchter; Amy Kramer; Kay-See Tan; Daniel F Heitjan; Glenda Rodgers; Maryann Gallagher; Shengfu Piao; Andrea B Troxel; Tracey L Evans; Angela M DeMichele; Katherine L Nathanson; Peter J O'Dwyer; Jonathon Kaiser; Laura Pontiggia; Lisa E Davis; Ravi K Amaravadi
Journal:  Autophagy       Date:  2014-05-20       Impact factor: 16.016

9.  Autophagy proteins regulate ERK phosphorylation.

Authors:  Nuria Martinez-Lopez; Diana Athonvarangkul; Priti Mishall; Srabani Sahu; Rajat Singh
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma.

Authors:  Reshma Rangwala; Yunyoung C Chang; Janice Hu; Kenneth M Algazy; Tracey L Evans; Leslie A Fecher; Lynn M Schuchter; Drew A Torigian; Jeffrey T Panosian; Andrea B Troxel; Kay-See Tan; Daniel F Heitjan; Angela M DeMichele; David J Vaughn; Maryann Redlinger; Abass Alavi; Jonathon Kaiser; Laura Pontiggia; Lisa E Davis; Peter J O'Dwyer; Ravi K Amaravadi
Journal:  Autophagy       Date:  2014-05-20       Impact factor: 16.016

View more
  6 in total

Review 1.  Aberrant regulation of autophagy in mammalian diseases.

Authors:  Wei Xie; Jun Zhou
Journal:  Biol Lett       Date:  2018-01       Impact factor: 3.703

2.  ALDH1A1 and HLTF modulate the activity of lysosomal autophagy inhibitors in cancer cells.

Authors:  Shengfu Piao; Rani Ojha; Vito W Rebecca; Arabinda Samanta; Xiao-Hong Ma; Quentin Mcafee; Michael C Nicastri; Meghan Buckley; Eric Brown; Jeffrey D Winkler; Phyllis A Gimotty; Ravi K Amaravadi
Journal:  Autophagy       Date:  2017-10-05       Impact factor: 16.016

Review 3.  Therapeutic Targeting of Autophagy.

Authors:  Christina G Towers; Andrew Thorburn
Journal:  EBioMedicine       Date:  2016-10-23       Impact factor: 8.143

4.  Casein Kinase-1-Alpha Inhibitor (D4476) Sensitizes Microsatellite Instable Colorectal Cancer Cells to 5-Fluorouracil via Authophagy Flux Inhibition.

Authors:  Morvarid Siri; Hamid Behrouj; Sanaz Dastghaib; Mozhdeh Zamani; Wirginia Likus; Sedigheh Rezaie; Jacek Hudecki; Saeed Khazayel; Marek J Łos; Pooneh Mokarram; Saeid Ghavami
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2021-09-18       Impact factor: 4.291

Review 5.  Circular RNAs act as regulators of autophagy in cancer.

Authors:  Zhixia Zhou; Yinfeng Zhang; Jinning Gao; Xiaodan Hao; Chan Shan; Jing Li; Cuiyun Liu; Yin Wang; Peifeng Li
Journal:  Mol Ther Oncolytics       Date:  2021-04-20       Impact factor: 7.200

6.  DUOX2 promotes the progression of colorectal cancer cells by regulating the AKT pathway and interacting with RPL3.

Authors:  Xue Zhang; Jing Han; Li Feng; Lianghui Zhi; Da Jiang; Bin Yu; Zhenya Zhang; Bo Gao; Cong Zhang; Meng Li; Lianmei Zhao; Guiying Wang
Journal:  Carcinogenesis       Date:  2021-02-11       Impact factor: 4.944

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.